CYNTHIA CARSTEN: Open Payments
NPI 1629449293 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,741 in 56 payments from 24 companies in 2025. Trend: 2023 $2,336 · 2024 $872 · 2025 $1,741
Food & beverage: $1,698Education: $43
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 8 | $438 |
| ABBVIE INC. | 12 | $222 |
| AstraZeneca Pharmaceuticals LP | 5 | $141 |
| E.R. Squibb & Sons, L.L.C. | 1 | $129 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| TerSera Therapeutics LLC | 2 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Genentech USA, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
Products named: DAXI, DAXXIFY, REBLOZYL, EPKINLY, KEYTRUDA, VENCLEXTA, ENHERTU, Zoladex.
Industry payments across AZ — which companies pay providers there.
